What companies does Inveready invest in?
Inveready has 5 funds that invest in seed capital companies with a high technological component, mainly in the ICT and biotechnology sectors.
For ICT companies, there are 5 funds, one for the biotechnology sector and 4 for the ICT sector.
Inveready Biotech II, the fund for the biotech sector, invests in early stage companies requiring between 1 and 4 M of investment and whose developments are related to the creation of new drugs, diagnostics and prognostics, and nutraceutical and functional products. Among its investees are successful companies such as Minoryx Therapheuticswhich received its first round of investment in 2013 and has currently received a €19M round from investors such as Ysios Capital, via Ysios BioFund II Innvierte and Caixa Capital Risk.
Inveready has 4 funds to invest in the ICT sector, Inveready first capital, Inveready first capital II, Inveready Seed Capital and Inveready Venture finance.
Inveready invests in very different sectors within the ICT field. One of the sectors that we have seen quite active this year is Big data. Inveready has invested in 3 big data startups in 2015: Innoquant, Bitext and Agile contenst.
In addition to big data, security, gaming and marketing are also sectors where we have seen a lot of investment.
What criteria does Inveready use to choose its investments?
Inveready receives between 500 and 1000 projects a year, and the criteria they use to choose the investees include, firstly, that they are projects that have passed the idea phase and that they are tested projects. The second sieve is that they are projects with a high technological depth and the third requirement is that the project team includes people with analytical skills who know how to measure the economic impact and the "go to market" of the project, who know how to sell it.
Inveready's latest operations : Innoquant, Buguroo and Bionaturis.
InnoquantInnoQuant, a company specialising in big data and mass data storage, has received a 1.8M round of funding to boost its proximity marketing platform called Moca internationally, and to strengthen InnoQuant's R&D&I area.
The investment will be made in instalments between this year and 2017.
Burguroo provides cloud-based security solutions for enterprises and financial institutions using a software as a service model.
Burguroo has closed a €3M round in which Ticnova, STS Inversions and Cube Ventures have also participated.
In the field of biotechnology, Bionaturis has signed with Inveready the potential acquisition of a division of Inveready that develops technologies for the purification of peptides, recombinant proteins and antibodies, both of therapeutic and industrial interest.
Other posts that may interest you
If you are looking for financing, please contact us. Abra-Invest has a team of experts in alternative financing in the tic sector at your disposal, fill in the contact form or call us on + 34 46424142.